| Jun 13 |
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
|
| Jun 13 |
Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
|
| Jun 12 |
How Luciana Preger Is Helping Advance Gilead’s Work in Oncology
|
| Jun 8 |
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
|
| Jun 7 |
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
|
| Jun 6 |
Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA
|
| Jun 6 |
Gilead’s seladelpar shows promise in primary biliary cholangitis trial
|
| Jun 6 |
Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA
|
| Jun 5 |
Gilead Sciences, Inc. (GILD) Jefferies 2024 Global Healthcare Conference
|
| Jun 5 |
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
|
